Previous close | 123.04 |
Open | 123.16 |
Bid | 128.86 x N/A |
Ask | 129.00 x N/A |
Day's range | 123.16 - 126.30 |
52-week range | 85.60 - 135.28 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 07 Nov 2024 - 11 Nov 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that after 11 years of service, Charles "Chuck" Dadswell will step down as General Counsel and Secretary on October 3. Dadswell has agreed to remain an Illumina employee, serving as an advisor to CEO Jacob Thaysen and the Board of Directors, through March 31, 2025. Scott Davies has been named acting General Counsel and Secretary while the company conducts a search for Dadswell's permanent suc
We came across a bullish thesis on Illumina, Inc. (ILMN) on Ocean Road Capital’s Substack by Ocean Road Capital. In this article, we will summarize the bulls’ thesis on ILMN. ILMN Technologies, Inc.’s share was trading at $132.27 as of Sept 25th. ILMN’s forward P/E was 29.41 according to Yahoo Finance. Illumina is a global leader in […]
While not a mind-blowing move, it is good to see that the Illumina, Inc. ( NASDAQ:ILMN ) share price has gained 23% in...